Elena Tirrò - Concepedia

Author

Elena Tirrò

University of Catania ORCID

Also Known As

E Tirrò, E. Tirrò, ELENA TIRRÒ, ELENA TIRRÓ, Elena Tirro, Elena Tirrò, Elena Tirro’, Elena Tirrò, Tirro, E

Publications

Citations

H-Index

Concepts

All Affiliations

University of Catania Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele University of Palermo Ospedale Garibaldi Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo

About

Elena Tirrò is an author at University of Catania specializing in cell biology, tumor biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	645
2	Cell Biology	3	3	645
3	Immunology	3	3	645
4	Cell Signaling	3	3	645
5	Pharmacology	1	1	56

Elena Tirrò

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells Cristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton, Journal of Clinical Investigation Mixed-phenotype Acute LeukemiaApoptosisImmunologyCell DeathStem Cell Biology	2009	556
Altered Expression of c-IAP1, Survivin, and Smac Contributes to Chemotherapy Resistance in Thyroid Cancer Cells Elena Tirrò, Maria Letizia Consoli, Michele Massimino, Cancer Research	2006	96
FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series Francesco Certo, Roberto Altieri, Massimiliano Maione, Operative Neurosurgery	2020	79
Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs Stefania Stella, Elena Tirrò, Enrico Conte, Molecular Cancer Therapeutics Mixed-phenotype Acute LeukemiaImmunologyCell DeathTumor BiologyMyeloid Neoplasia	2013	56
Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas Giuseppe Broggi, Lucia Salvatorelli, Davide Barbagallo, Cancers	2021	41
BCR‐ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein Pietro Buffa, Chiara Romano, Alessandro Pandini, The FASEB Journal	2013	33
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells Cristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton, Journal of Clinical Investigation Cell AutophagyMedicineReceptor Tyrosine KinaseApoptosisAutophagy	2013	33
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 Elena Tirrò, Michele Massimino, Chiara Romano, Frontiers in Oncology	2019	31
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation Michele Massimino, Maria Letizia Consoli, Maria Mesuraca, Carcinogenesis	2014	29
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications Elena Tirrò, Michele Massimino, Giuseppe Broggi, Frontiers in Oncology	2022	29

Page 1